Replimune Group, Inc. Gains 107.02%

Replimune Group, Inc. (REPL:NASDAQ) shot up at $11.2, a gain of 107%. On Fri, Jul 31, 2026, REPL:NASDAQ hit a New 2-Week High of $11.2. The stock appeared on our News Catalysts scanner on Fri, Jul 31, 2026 at 06:19 PM in the 'BIOTECH' category. From Fri, Jul 17, 2026, the stock recorded 40.00% Up Days and 45.45% Green Days

The stock spiked on Tue, Jun 30, 2026 at $12.5 with a volume of 4M+.

About Replimune Group, Inc. (REPL:NASDAQ)

Replimune Group Inc is a clinical-stage biotechnology company. Its use proprietary Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The company's pipeline products include RP1, RP2, and RP3.